Trials / Completed
CompletedNCT01417312
Metabolic Effects of a Green Tea Extract in Multiple Sclerosis Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Charite University, Berlin, Germany · Academic / Other
- Sex
- All
- Age
- 20 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to investigate metabolic effects of a standardized green tea extract, containing a defined amount of epigallocatechin-3-gallate (EGCG), in multiple sclerosis patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Capsules with 160 mg Teavigo (at least 94% EGCG) | Daily intake of 600 mg EGCG for 3 months |
| DIETARY_SUPPLEMENT | Placebo | Daily intake of placebo capsules for 3 months |
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2012-11-01
- Completion
- 2013-01-01
- First posted
- 2011-08-16
- Last updated
- 2021-07-29
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01417312. Inclusion in this directory is not an endorsement.